NLIGHT, INC.
Business
NLIGHT, INC. designs, manufactures, and sells high‑power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. Its main products include high‑power semiconductor lasers, programmable and serviceable fiber lasers, high‑performance fiber amplifiers, high energy pulsed fiber lasers, beam combination and control systems, and laser sensing solutions. The business operates through two reportable segments: Laser Products (semiconductor lasers, fiber lasers, and amplifiers) and Advanced Development (directed energy and laser sensing research and prototyping). NLIGHT distributes globally via direct sales, certified distributors, and independent representatives across the United States, Asia, Europe, the Middle East, Australia, and South America.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 261 | 199 | 210 | 242 | 270 | |
| Total cost of revenue | 183 | 166 | 164 | 191 | 193 | |
| Gross profit | 78 | 33 | 46 | 51 | 77 | |
| Research and development | 48 | 45 | 46 | 54 | 55 | |
| Sales, general, and administrative | 54 | 49 | 46 | 48 | 53 | |
| Restructuring | 2 | 4 | 817,000 | 4 | 0 | |
| Total operating expenses | 105 | 99 | 93 | 106 | 108 | |
| Loss from operations | −27 | −66 | −47 | −55 | −30 | |
| Interest income | 5 | 2 | 1 | — | — | |
| Interest expense | −1 | −105,000 | −67,000 | — | — | |
| Other (expense) income, net | −40,000 | 3 | 3 | 338,000 | 336,000 | |
| Loss before income taxes | −23 | −61 | −43 | −54 | −30 | |
| Income tax expense (benefit) | 699,000 | −76,000 | −978,000 | 344,000 | −375,000 | |
| Net loss | −23 | −61 | −42 | −55 | −30 | |
| Net loss per share, basic (in dollars per share) | −0.47 | −1.27 | −0.9 | −1.23 | −0.7 | |
| Net loss per share, diluted (in dollars per share) | −0.47 | −1.27 | −0.9 | −1.23 | −0.7 | |
| Shares used in per share calculations, basic (in shares) | 50 | 48 | 46 | 44 | 42 | |
| Shares used in per share calculations, diluted (in shares) | 50 | 48 | 46 | 44 | 42 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 99 | 66 | 53 | 58 | 147 | |
| Marketable securities | 35 | 35 | 60 | 50 | 0 | |
| Accounts receivable, net of allowances of $520 and $1,800 | 51 | 35 | 40 | 38 | 42 | |
| Inventory | 45 | 41 | 52 | 68 | 74 | |
| Prepaid expenses and other current assets | 13 | 18 | 16 | 17 | 15 | |
| Total current assets | 243 | 194 | 221 | 231 | 277 | |
| Restricted cash | 322,000 | 259,000 | 256,000 | 252,000 | 250,000 | |
| Lease right-of-use assets | 15 | 11 | 13 | 14 | 17 | |
| Property, plant and equipment, net | 42 | 47 | 52 | 61 | 56 | |
| Intangible assets, net | 0 | 833,000 | 2 | 4 | 7 | |
| Goodwill | 12 | 12 | 12 | 12 | 12 | |
| Other assets, net | 2 | 5 | 7 | 7 | 4 | |
| Total assets | 315 | 270 | 307 | 329 | 374 | |
| Accounts payable | 21 | 15 | 12 | 18 | 26 | |
| Accrued liabilities | 19 | 13 | 13 | 13 | 15 | |
| Deferred revenues | 1 | 4 | 5 | 1 | 2 | |
| Current portion of lease liabilities | 3 | 2 | 3 | 3 | 3 | |
| Line of credit | 20 | 0 | — | — | — | |
| Total current liabilities | 64 | 34 | 33 | 34 | 46 | |
| Non-current income taxes payable | 6 | 6 | 5 | 7 | 7 | |
| Long-term lease liabilities | 13 | 10 | 11 | 13 | 15 | |
| Other long-term liabilities | 5 | 4 | 3 | 4 | 4 | |
| Total liabilities | 88 | 54 | 52 | 58 | 71 | |
| Common stock - $0.0001 par value; 190,000 shares authorized, 51,163 and 48,948 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 16,000 | 16,000 | 16,000 | 16,000 | 15,000 | |
| Additional paid-in capital | 578 | 545 | 521 | 496 | 471 | |
| Accumulated other comprehensive loss | −3 | −3 | −2 | −3 | −587,000 | |
| Accumulated deficit | −349 | −325 | −264 | −223 | −168 | |
| Total stockholders equity | 227 | 216 | 254 | 271 | 302 | |
| Total liabilities and stockholders equity | 315 | 270 | 307 | 329 | 374 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation | 12 | 13 | 12 | 11 | 9 | |
| Amortization | 2 | 5 | 4 | 5 | 6 | |
| (Increase) reduction in carrying amount of right-of-use assets | −4 | 2 | 1 | 3 | 3 | |
| (Recoveries of) provision for losses on accounts receivable | −1 | 1 | 27,000 | 4,000 | −70,000 | |
| Stock-based compensation | 33 | 25 | 26 | 27 | 38 | |
| Deferred income taxes | 159,000 | −651,000 | 7,000 | 4,000 | 37,000 | |
| Loss on disposal of property, plant and equipment | 160,000 | 194,000 | 542,000 | 51,000 | 16,000 | |
| Accrued interest earned on marketable securities | −500,000 | 0 | 0 | — | — | |
| Non-cash restructuring charges | 1 | 1 | 0 | 3 | 0 | |
| Accounts receivable, net | −15 | 3 | −2 | 3 | −10 | |
| Inventory | −4 | 11 | 15 | 5 | −19 | |
| Prepaid expenses and other current assets | 4 | −2 | 1 | −2 | −4 | |
| Other assets, net | 1 | −1 | −1 | −5 | −570,000 | |
| Accounts payable | 6 | 3 | −5 | −6 | 3 | |
| Accrued and other long-term liabilities | 6 | 706,000 | −1 | −577,000 | −199,000 | |
| Deferred revenues | −2 | −1 | 3 | −208,000 | −909,000 | |
| Lease liabilities | 4 | −2 | −1 | −2 | −3 | |
| Non-current income taxes payable | 277,000 | 204,000 | −1 | −13,000 | −507,000 | |
| Net cash provided by (used in) operating activities | 21 | −2 | 10 | −15 | −7 | |
| Proceeds from sale of fixed assets | 542,000 | 0 | 0 | — | — | |
| Purchases of property, plant and equipment | −9 | −8 | −5 | −21 | −19 | |
| Purchase of marketable securities | −79 | −89 | −128 | −100 | 0 | |
| Proceeds from maturities and sales of marketable securities | 78 | 113 | 119 | 50 | 0 | |
| Net cash (used in) provided by investing activities | −9 | 17 | −14 | −72 | −22 | |
| Proceeds from line of credit | 20 | 0 | 0 | — | — | |
| Proceeds from employee stock plan purchases | 3 | 3 | 2 | 2 | 2 | |
| Proceeds from stock option exercises | 300,000 | 500,000 | 600,000 | 1 | 1 | |
| Tax payments related to stock award issuances | −3 | −5 | −4 | −5 | −11 | |
| Net cash provided by (used in) financing activities | 20 | −1 | −859,000 | −1 | 74 | |
| Effect of exchange rate changes on cash | 264,000 | −406,000 | 256,000 | −477,000 | −235,000 | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 33 | 13 | −5 | −89 | 44 | |
| Cash paid for interest | 1 | 61,000 | 40,000 | 0 | 117,000 | |
| Operating cash outflows from operating leases | 3 | 4 | 4 | 4 | 4 | |
| Right-of-use assets obtained in exchange for lease liabilities | 7 | 1 | 2 | 1 | 8 | |
| Accrued purchases of property, equipment and patents | 409,000 | 298,000 | 745,000 | 207,000 | 3 |